Literature DB >> 19473773

Colonic fermentation--more than meets the nose.

R P Arasaradnam1, M W Pharaoh, G J Williams, C U Nwokolo, K D Bardhan, S Kumar.   

Abstract

Fermentation of undigested foods in the colon by its resident bacteria affects not only colonic health (protection against inflammation and tumour formation) but also influences metabolic health. Studying fermentation directly is difficult for lack of access. We hypothesise that the anatomical structure of the colon is suited to act as a fermenting chamber with the gaseous molecules (VOCs) emitted having direct effects on the colonocytes as well as gut neural and metabolic effects. We refer to this complex system as the 'fermentome', and further hypothesise that alteration in the 'fermentome' through dietary modification will have a direct impact on colonic as well as metabolic health and disease. The VOCs emitted may play a role in bacterial chemical signalling within the colon but importantly could also function as a 'gas' biomarker. Measurement of such VOCs through non-invasive methods would have important application as a hypothesis-generating tool with subsequent clinical application.

Entities:  

Mesh:

Year:  2009        PMID: 19473773     DOI: 10.1016/j.mehy.2009.04.027

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  7 in total

Review 1.  Immunomodulatory dietary polysaccharides: a systematic review of the literature.

Authors:  Jane E Ramberg; Erika D Nelson; Robert A Sinnott
Journal:  Nutr J       Date:  2010-11-18       Impact factor: 3.271

2.  An open-label dosing study to evaluate the safety and effects of a dietary plant-derived polysaccharide supplement on the N-glycosylation status of serum glycoproteins in healthy subjects.

Authors:  A Alavi; O Fraser; E Tarelli; M Bland; J Axford
Journal:  Eur J Clin Nutr       Date:  2011-01-12       Impact factor: 4.016

3.  Application of a novel tool for diagnosing bile acid diarrhoea.

Authors:  James A Covington; Eric W Westenbrink; Nathalie Ouaret; Ruth Harbord; Catherine Bailey; Nicola O'Connell; James Cullis; Nigel Williams; Chuka U Nwokolo; Karna D Bardhan; Ramesh P Arasaradnam
Journal:  Sensors (Basel)       Date:  2013-09-06       Impact factor: 3.576

4.  Differentiating coeliac disease from irritable bowel syndrome by urinary volatile organic compound analysis--a pilot study.

Authors:  Ramesh P Arasaradnam; Eric Westenbrink; Michael J McFarlane; Ruth Harbord; Samantha Chambers; Nicola O'Connell; Catherine Bailey; Chuka U Nwokolo; Karna D Bardhan; Richard Savage; James A Covington
Journal:  PLoS One       Date:  2014-10-16       Impact factor: 3.240

5.  Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis.

Authors:  Ramesh P Arasaradnam; Michael J McFarlane; Courtenay Ryan-Fisher; Erik Westenbrink; Phoebe Hodges; Paula Hodges; Matthew G Thomas; Samantha Chambers; Nicola O'Connell; Catherine Bailey; Christopher Harmston; Chuka U Nwokolo; Karna D Bardhan; James A Covington
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

Review 6.  Are Volatile Organic Compounds Accurate Markers in the Assessment of Colorectal Cancer and Inflammatory Bowel Diseases? A Review.

Authors:  Filippo Vernia; Marco Valvano; Stefano Fabiani; Gianpiero Stefanelli; Salvatore Longo; Angelo Viscido; Giovanni Latella
Journal:  Cancers (Basel)       Date:  2021-05-13       Impact factor: 6.639

7.  Simultaneous Assessment of Urinary and Fecal Volatile Organic Compound Analysis in De Novo Pediatric IBD.

Authors:  Sofia El Manouni El Hassani; Sofie Bosch; Jesse P M Lemmen; Marina Brizzio Brentar; Ibrahim Ayada; Alfian N Wicaksono; James A Covington; Marc A Benninga; Nanne K H de Boer; Tim G J de Meij
Journal:  Sensors (Basel)       Date:  2019-10-16       Impact factor: 3.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.